rs1162744670
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178161.3(PTF1A):c.265C>A(p.Leu89Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,313,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_178161.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTF1A | NM_178161.3 | c.265C>A | p.Leu89Ile | missense_variant | 1/2 | ENST00000376504.4 | NP_835455.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTF1A | ENST00000376504.4 | c.265C>A | p.Leu89Ile | missense_variant | 1/2 | 1 | NM_178161.3 | ENSP00000365687.3 | ||
PTF1A | ENST00000638469.1 | c.114+118C>A | intron_variant | 5 | ENSP00000491649.1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151856Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000267 AC: 3AN: 11236Hom.: 0 AF XY: 0.000141 AC XY: 1AN XY: 7092
GnomAD4 exome AF: 0.000121 AC: 141AN: 1162136Hom.: 0 Cov.: 33 AF XY: 0.000136 AC XY: 76AN XY: 559060
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151856Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74162
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.265C>A (p.L89I) alteration is located in exon 1 (coding exon 1) of the PTF1A gene. This alteration results from a C to A substitution at nucleotide position 265, causing the leucine (L) at amino acid position 89 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Jul 27, 2017 | ACMG Criteria:PP3 (2 predictors), BP4 (8 predictors), PM2 (absent in database) - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 89 of the PTF1A protein (p.Leu89Ile). This variant is present in population databases (no rsID available, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PTF1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 549537). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at